According to data from amfAR, the Foundation for AIDS Research, about 1.3 million people are on HIV/AIDS treatment in Kenya, ...

The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...

The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...

The Trump administration's global aid freeze is threatening the lives of HIV-positive orphans at Nyumbani Children's Home in ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

Legislation that would remove a criminal penalty for intentionally transferring HIV to another person sailed through both the ...

Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...

A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by ...

A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

The U.S. decision in January to freeze all funding for U.S. foreign assistance, including for the U.S. President's Emergency ...

An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...